Home / Inspections / 1173861

FDA Inspection 1173861 — Blood Bank Of Delmarva, Inc, A Division of New York Blood Center

Blood Bank Of Delmarva, Inc, A Division of New York Blood Center — FEI 2577619

The FDA completed an inspection of Blood Bank Of Delmarva, Inc, A Division of New York Blood Center on March 18, 2022 in Dover, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dover, DE (United States)

Facility

Other inspections at this facility

  • 1246981 (NAI Fri Aug 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1090248 (NAI Fri Mar 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014321 (NAI Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927978 (NAI Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 838325 (NAI Fri Jun 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources